Licensing Considerations and eCOA Vendor Collaborations

LifeSci Talks

Jan 30 2024 | 00:26:26

00:00 / 00:26:26

Show Notes

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacey Higgins, Associate Director, COA & Digital Implementation Team at AbbVie, to cover the intricacies of clinical trial licensing, contract variations among eCOA providers, the importance of sponsor involvement, and the challenges of validated translations. Explore the complexities that can arise in these critical aspects of clinical trials

Other Episodes

Episode 15

August 08, 2024 • 00:01:28

From Interview to Endpoint: Understanding the Importance of Patient Listening to Build Better Outcomes

In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with John Reites, Co-Founder and CEO...

Episode 3

August 11, 2023 • 00:13:29

Considerations and Opportunities in Capturing Oncology Patients’ PRO Data with Bill Byrom

In this episode, host Mark Wade is joined by Bill Byrom, the VP of Product Intelligence and Positioning at Signant Health, as they explore...

Episode 16

November 08, 2024 • 00:24:59

Effective Rater Training: A Critical but Overlooked Part of COA Administration

In this episode of LifeSci Talks, TransPerfect Life Sciences’ Global Practice Leader Mark Wade sits down with Kelly Dumais PhD, Director of eCOA Science...